Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.

待确认 20 由 karry 发布于 2026/6/23 15:14:09

DOI:10.1016/S1470-2045(18)30576-X
作者：Suzanne Trudel, Nikoletta Lendvai, Rakesh Popat, Peter M Voorhees, Brandi Reeves, Edward N Libby, Paul G Richardson, Larry D Anderson, Heather J Sutherland,&nbs
文献类型：期刊论文
补充材料：仅需补充材料
文献链接：https://doi.org/10.1016/S1470-2045(18)30576-X

Elsevier

Abstract：Background: B-cell maturation antigen (BCMA) is a cell-surface receptor of the tumour necrosis superfamily required for plasma cell survival. BMCA is universally detected on patient-derived

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

4小时前

蟹黄

202606231712177417430.pdf

6小时前

Book学术机器人

2026/6/23 15:14:09 未找到该文献，机器人已退出，请等待人工下载

2026/6/23 15:14:09 Book学术AI机器人收到请求，开始寻找文献

2026/6/23 15:14:09 已向机器人发送请求

6小时前

karry 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierQuaternary-ammonium chitosan, a promising packaging material in the food industry